BRPI0822997A2 - Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos - Google Patents

Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos

Info

Publication number
BRPI0822997A2
BRPI0822997A2 BRPI0822997-0A BRPI0822997A BRPI0822997A2 BR PI0822997 A2 BRPI0822997 A2 BR PI0822997A2 BR PI0822997 A BRPI0822997 A BR PI0822997A BR PI0822997 A2 BRPI0822997 A2 BR PI0822997A2
Authority
BR
Brazil
Prior art keywords
immunomodulatory
extracts
manufacture
methods
lactobacillus bacteria
Prior art date
Application number
BRPI0822997-0A
Other languages
English (en)
Inventor
Jacques Alain Bauer
Marco Salvagni
Jean-Pierre Leon Vigroux
Laetitia Leela Gisele Chalvet
Carlo Chiavaroli
Original Assignee
Om Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Pharma filed Critical Om Pharma
Publication of BRPI0822997A2 publication Critical patent/BRPI0822997A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0822997-0A 2008-09-04 2008-09-04 Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos BRPI0822997A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/010350 WO2010027344A1 (en) 2008-09-04 2008-09-04 Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
BRPI0822997A2 true BRPI0822997A2 (pt) 2015-06-23

Family

ID=41797341

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822997-0A BRPI0822997A2 (pt) 2008-09-04 2008-09-04 Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos

Country Status (11)

Country Link
JP (1) JP2012502026A (pt)
KR (1) KR20110051268A (pt)
CN (1) CN102143756A (pt)
AU (1) AU2008361375B2 (pt)
BR (1) BRPI0822997A2 (pt)
CA (1) CA2733249A1 (pt)
IL (1) IL211041A0 (pt)
MX (1) MX2011002080A (pt)
RU (1) RU2500412C2 (pt)
WO (1) WO2010027344A1 (pt)
ZA (1) ZA201100899B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2837751C (en) 2011-02-02 2018-01-09 Justbio Inc. Functional foods and beverages with synergistic properties to promote homeostasis
WO2012130968A1 (en) * 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
WO2012130966A1 (en) * 2011-03-29 2012-10-04 Nestec S.A. Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
US12268718B2 (en) 2012-01-16 2025-04-08 Labyrinth Holdings Llc Control of cellular redox levels
CA3208225A1 (en) 2012-01-16 2013-07-25 Elizabeth Mckenna Compositions and methods for the treatment of hepatitic diseases and disorders
JP2015535829A (ja) 2012-09-21 2015-12-17 マッケーナ、エリザベス 天然に存在するＣｐＧオリゴヌクレオチド組成物およびその治療的適用
US20150017208A1 (en) * 2013-07-12 2015-01-15 National Yang-Ming University Lactic acid bacterium having immunomodulatory and anti-allergic effects
JP6491422B2 (ja) * 2013-09-26 2019-03-27 雪印メグミルク株式会社 免疫疾患予防剤
JP6821643B2 (ja) * 2013-09-26 2021-01-27 雪印メグミルク株式会社 免疫疾患予防剤
CN104957260B (zh) * 2014-03-07 2018-07-24 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
KR101627806B1 (ko) * 2014-06-23 2016-06-07 한국식품연구원 락토바실러스 속 균주의 면역증강 활성을 증가시키는 배양 방법
JP6940305B2 (ja) 2017-06-01 2021-09-22 株式会社明治 チーズ風味素材の製造方法
KR102335710B1 (ko) 2017-10-31 2021-12-07 (주)아모레퍼시픽 유산균 유래의 세포밖 베지클을 포함하는 면역조절용 조성물
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
MY202164A (en) 2018-05-09 2024-04-09 Kobiolabs Inc Lactobacillus paracasei strain and use thereof
US12220394B2 (en) 2018-06-07 2025-02-11 National University Corporation Kanazawa University Pharmaceutical composition for prevention or treatment of kidney damage
JP7364165B2 (ja) * 2018-06-07 2023-10-18 国立大学法人金沢大学 腎障害の予防又は治療用の医薬組成物
CN109007842A (zh) * 2018-10-29 2018-12-18 广州普维君健药业有限公司 具有防治过敏功效的益生菌组合物及其应用
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
KR102156829B1 (ko) * 2019-02-22 2020-09-18 가톨릭대학교 산학협력단 마이크로바이옴 혼합물을 포함하는 면역 질환의 예방 및 치료용 조성물
CA3132564A1 (en) * 2019-03-14 2020-09-17 Om Pharma Sa Process for making stable bacterial extracts and their use as pharmaceuticals
CN110643541B (zh) * 2019-10-25 2021-08-24 江南大学 一株可调节过敏性哮喘Th2/Th1平衡的干酪乳杆菌及其应用
CN111053789A (zh) * 2019-11-26 2020-04-24 湖南营养树生物科技有限公司 调节免疫系统的方法和组合物
EP4084784A4 (en) * 2020-01-13 2024-01-17 Monash University Compositions and methods
CN111548961A (zh) * 2020-05-15 2020-08-18 郑州和合生物工程技术有限公司 改善过敏性疾病的益生菌组合物、益生菌组合物菌粉及制备方法，应用
EP4161558A4 (en) * 2020-06-06 2024-06-19 Quorum Innovations, LLC Materials and methods for inhibiting a viral infection, including a coronavirus infection
CN111991428A (zh) * 2020-06-12 2020-11-27 郑州和合生物工程技术有限公司 一种具有改善哮喘作用的益生菌组合物及其制备方法
CN112057479B (zh) * 2020-11-16 2021-02-12 河北一然生物科技有限公司 一种能够缓解抗生素引起腹泻的益生菌组合物
KR102424594B1 (ko) * 2020-11-30 2022-07-25 파이토지노믹스 주식회사 항염 활성 및 유해 미생물에 대한 항균 활성을 가지는 락토바실러스 퍼멘텀 okbl-l.fe 1 균주 및 이의 용도
JP7723917B2 (ja) * 2021-05-11 2025-08-15 スノーデン株式会社 トル様受容体２結合物質の製造方法
KR20230001127A (ko) 2021-06-28 2023-01-04 농업회사법인 산청바이오진생마을 주식회사 새싹 인삼 라떼 제조방법
WO2023167563A1 (ko) * 2022-03-03 2023-09-07 한국생명공학연구원 N-카바밀-l-글루탐산을 포함하는 염증성 질환의 치료용 조성물
CN114774302B (zh) * 2022-03-09 2023-06-16 善恩康生物科技（苏州）有限公司 植物乳杆菌cqpc02在制备用于预防和/或治疗狼疮性肾炎的产品中的应用
CN119855897A (zh) * 2022-09-28 2025-04-18 生合生物科技股份有限公司 使用共生组合物来抗鼠伤寒沙门杆菌感染的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH532903A (fr) * 1971-06-25 1973-01-31 Nestle Sa Procédé d'extraction de protéines à partir de cellules de microorganismes
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
RU2302458C2 (ru) * 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US7025998B2 (en) * 2003-05-30 2006-04-11 Rotta Research Laboratorium S.P.A. Phytoestrogens and probiotic for women's health
CA2557834C (en) * 2004-03-04 2012-05-22 E-L Management Corporation Skin treatment method with lactobacillus extract
EP2261323A1 (en) * 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
JP2007269737A (ja) * 2006-03-31 2007-10-18 Morinaga Milk Ind Co Ltd インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤

Also Published As

Publication number Publication date
JP2012502026A (ja) 2012-01-26
AU2008361375A1 (en) 2010-03-11
AU2008361375B2 (en) 2014-05-22
RU2500412C2 (ru) 2013-12-10
WO2010027344A1 (en) 2010-03-11
MX2011002080A (es) 2011-03-29
IL211041A0 (en) 2011-04-28
CN102143756A (zh) 2011-08-03
RU2011112781A (ru) 2012-10-10
KR20110051268A (ko) 2011-05-17
CA2733249A1 (en) 2010-03-11
ZA201100899B (en) 2012-05-30

Similar Documents

Publication Publication Date Title
BRPI0822997A2 (pt) Extratos imunomoduladores de bactérias lactobacillus e métodos para fabricação e uso dos mesmos
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI0916269A2 (pt) dispositivo de modificação de tecido e seu método de uso
BRPI1011404A2 (pt) mutantes e usos dos mesmos
BRPI0909077A2 (pt) Artigos multicamadas e métodos de preparo e uso dos mesmos
BR112013013167A2 (pt) inibidores de bromodomínio e usos dos mesmos
PT2424896E (pt) Anticorpos anti-ceacam1 e métodos de utilização dos mesmos
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
BRPI1010024A2 (pt) derivados de aminopirrolidinona e uso dos mesmos
BRPI1007175A2 (pt) Polipeptídeos hidroxifenilpriruvato dioxigenase mutantes e métodos de uso
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
EP2301812A4 (en) PARKING AID DEVICE AND PARKING AID METHOD
HUE036439T2 (hu) Antimikrobiális készítmények és azok alkalmazási módszerei
BRPI1009847A2 (pt) conectores médicos e métodos de uso
BR112012004375A2 (pt) toalha de praia e método de toalha de praia
BRPI0918693A2 (pt) dispositivos para amostragem e métodos para concentração de microorganismos
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BRPI0924440A2 (pt) aparelho para restauração óssea da espinha e métodos de utilização
BRPI1005960A2 (pt) sistema de implante e ultilização de um sistema de implante
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0907575A2 (pt) Ligação de propriedades visuais de gráficos e células dentro de tabelas
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
IL213450A0 (en) Modified rsv f proteins and methods of their use

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.